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Mechanical punctate pain threshold is
associated with headache frequency
and phase in patients with migraine
Li-Ling Hope Pan1 , Yen-Feng Wang1,2,3, Kuan-Lin Lai1,2,3,4 ,
Wei-Ta Chen1,2,3, Shih-Pin Chen1,2,3,4,5 , Yu-Hsiang Ling2 ,
Li-Wei Chou6, Rolf-Detlef Treede7 and Shuu-Jiun Wang1,2,3
Abstract
Objective: Previous studies regarding the quantitative sensory testing are inconsistent in migraine. We hypothesized
that the quantitative sensory testing results were influenced by headache frequency or migraine phase.
Methods: This study recruited chronic and episodic migraine patients as well as healthy controls. Participants under-
went quantitative sensory testing, including heat, cold, and mechanical punctate pain thresholds at the supraorbital area
(V1 dermatome) and the forearm (T1 dermatome). Prospective headache diaries were used for headache frequency and
migraine phase when quantitative sensory testing was performed.
Results: Twenty-eight chronic migraine, 64 episodic migraine and 32 healthy controls completed the study. Significant
higher mechanical punctate pain thresholds were found in episodic migraine but not chronic migraine when compared
with healthy controls. The mechanical punctate pain thresholds decreased as headache frequency increased then
nadired. In episodic migraine, mechanical punctate pain thresholds were highest (p< 0.05) in those in the interictal
phase and declined when approaching the ictal phase in both V1 and T1 dermatomes. Linear regression analyses showed
that in those with episodic migraine, headache frequency and phase were independently associated with mechanical
punctate pain thresholds and accounted for 29.7% and 38.9% of the variance in V1 (p¼ 0.003) and T1 (p< 0.001)
respectively. Of note, unlike mechanical punctate pain thresholds, our study did not demonstrate similar findings for heat
pain thresholds and cold pain thresholds in migraine.
Conclusion: Our study provides new insights into the dynamic changes of quantitative sensory testing, especially
mechanical punctate pain thresholds in patients with migraine. Mechanical punctate pain thresholds vary depending
on headache frequency and migraine phase, providing an explanation for the inconsistency across studies.
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Introduction
Migraine is one of the most common and disabling
disorders (1). Altered cortical activity (2–4) and proc-
essing of sensory stimuli (5) have been reported
in patients with migraine. Quantitative sensory
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testing (QST), which measures cutaneous sensory sensi-
tivity changes and processing of sensory stimuli, have
long been studied in patients with migraine (5–7).
However, results are inconsistent. Some studies report
hypersensitized cutaneous pain threshold, including
heat-induced pain (8–12), cold-induced pain (8,13),
and pressure pain (14,15); however, several other studies
(10,16–19) suggest patients with migraine and controls
have similar thresholds. Moreover, changes in punctate
pain thresholds haven’t been well addressed in this
patient group compared with other stimuli.
The reasons for QST discrepancies in migraine
patients are unknown. Few reports have studied the
relationship between pain thresholds and migraine
attacks. Because the characteristics of migraine are
dynamic, sensitivity thresholds may change throughout
the migraine phases cycle (e.g. interictal, preictal, ictal,
and postictal phases). Many previous studies recruited
migraine patients when they were headache free, but in
some studies the migraine phase was not well classified.
In addition, by influencing the cortical excitability,
headache frequency may alter QST results. Two
recent studies reported lower heat pain threshold
(HPT) in migraine patients with higher headache fre-
quency (20) or shorter interval to the next headache
attack (9).
This study sought to investigate how headache fre-
quency and migraine phase are related to pain sensitiv-
ity using heat-, cold-, and mechanical punctate-induced
pain stimuli in migraine patients with varying headache
frequencies and migraine phases. We hypothesized that
pain sensitivity would be dynamic in patients with
migraine regarding the headache attacks.
Methods
Participants
We recruited migraine patients from 2013 to 2018, who
were diagnosed by board-certified neurologists at the
Headache Clinic of Taipei Veterans General Hospital
according to the International Classification of
Headache Disorders (ICHD-3 beta or ICHD-3)
(21,22). Patients’ demographics and clinical profiles
were obtained from an intake form and verified face-
to-face by neurologists. All migraine patients also
completed the Migraine Disability Scale (MIDAS) to
evaluate migraine-related disability in the prior 3
months and the Hospital Anxiety and Depression
Scale (HADS) for anxious and depressive state in the
prior week. In addition, sex- and age-matched healthy
controls (HCs) without any history of migraine or
other primary headaches were recruited. Infrequent
tension-type headache (<1 headache day/month) was,
however, allowed. Of note, we only recruited patients
whose major headache is migraine. Apart from the
migraine diagnosis in the patient groups, both patients
and HCs were normal in physical and neurological
examinations and did not have any systemic diseases,
major psychiatric disorders or conditions incompatible
with the study.
None of the recruited migraine patients were taking
migraine preventive agents; however, acute abortive
medications were allowed but not on the day of QST.
Patients were asked to document headache diaries for
at least 4 weeks at baseline (i.e. prior to QST) and
maintain the diaries for at least 2 weeks after QST to
determine the migraine phase of the testing day (see
below for definitions). The study protocol was
approved by the Institutional Review Board at the
Taipei Veterans General Hospital. All participants pro-
vided informed consent prior to participation. The
study procedures followed the Declaration of
Helsinki. Data from this study are available from the
corresponding author upon request.
Quantitative sensory testing
The subjects were scheduled to undergo QST and were
re-scheduled if abortive treatment was used within
3 days of testing. Participants laid comfortably in the
supine position during the assessment. Assessment
target areas included the left supraorbital (i.e. the first
branch of the trigeminal nerve dermatome, V1) and
proximal medio-ventral forearm (i.e. the first thoracic
nerve dermatome, T1). There were breaks between each
stimulus. All sensory stimuli types were delivered five
times; the two extreme values were excluded, and the
average values were calculated from the other three
recordings for further analyses. The order of stimula-
tion sites was randomized, while the order of stimula-
tion types was fixed to reduce the intra-individual
variance.
Heat and cold pain thresholds. Heat pain threshold (HPT)
and cold pain threshold (CPT) were determined using
the Medoc TSA-II NeuroSensory Analyzer (Medoc
Ltd., Israel) with a 30 mm 30 mm Thermode placed
on the testing area skin and secured with Velcro straps.
To determine the HPT, five heat stimuli, starting at
32 0.5C with a cut-off temperature of 50C, were
given at the increasing rate of 1C per second; and to
determine CPT, five cold stimuli, starting at 32 0.5C
with a cut-off temperature at 0C, were given at the
decreasing rate of 1C per second (23).
Mechanical punctate pain threshold. Mechanical punctate
stimuli were given with the standard rigid electronic
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von Frey filament (ITTC 2392, IITC Life Science Inc.,
USA). The mechanical punctate pain threshold
(MPPT) was defined as the lowest intensity perceived
as painful for participants. Participants were instructed
to inform the examiner immediately upon painful sen-
sation. Thresholds were determined with five series of
ascending stimulus intensity, applied at 25g/s (24).
Headache frequency and migraine phases
Prospective paper headache diaries were used to deter-
mine headache frequency (i.e. number of headache
days per 4 weeks, designated as monthly headache
days, MHD) (25) before QST. Participants who com-
pleted less than 75% of the baseline headache diary
were excluded from the analyses. Participants’ migraine
phases of the QST day were determined based on their
headache diaries: a) preictal phase defined as within 72
hours of the next headache, b) postictal phase defined
as within 24 hours following the headache, c) ictal
phase defined as during headache attacks, and d) inter-
ictal phase.
Statistical analysis
All statistical analyses were performed in SPSS version
22.0 (IBM, Armonk, NY, USA). Correlation and
linear regression analyses assessed headache profiles
and pain thresholds. Continuous variables were com-
pared between groups, namely episodic migraine (EM),
chronic migraine (CM) and HC groups, with t-tests or
one-way analysis of variance (ANOVA) tests with post-
hoc least significant difference (LSD) test. Categorical
variables were compared between groups with the chi-
square test. We compared the relationship between
pain thresholds and headache frequency, as well as
the differences in pain thresholds and cyclic changes
of pain thresholds between groups. All tests were
two-tailed, and the significance level was set at
p< 0.05. The data were presented as means with stan-
dard deviations (SD) or standard errors (SE).
Results
Participant demographics
We recruited 104 migraine patients (35.7 10.0 years,
F/M: 85/19) and 32 HCs (37.8 7.0 years, F/M: 27/5).
Twelve migraine patients were excluded from analyses
due to incomplete baseline headache diaries. The final
sample for analysis included 92 migraine patients with
a 97.2 6.4% baseline headache diaries completion
rate (range from 78.6% to 100%). There were 28 CM
patients (37.3 11.4 years, F/M: 24/4) and 64 EM
patients (34.2 8.7 years, F/M: 52/12). Table 1 shows
the demographics and the clinical data of patients and
HC groups. No significant differences were found
between groups regarding age and sex. The headache
frequency (p< 0.001), HADS_A (p< 0.001), and
HADS_D (p¼ 0.001) were significantly higher in the
CM group compared with the EM group.
Pain thresholds
Table 2 shows HPTs, CPTs, and MPPTs of all three
groups. EM participants had higher MPPTs compared
with CM participants in both dermatomes
(V1: 115.8 41.0 vs. 94.5 34.5, p¼ 0.021 and T1:
127.0 72.5 vs. 85.5 33.8, p¼ 0.003) and HCs in V1
dermatome (115.8 41.0 vs. 96.0 43.9, p¼ 0.025).
Pain thresholds were similar between CM participants
and HCs. Of note, the results of MPPT were similar
after logarithmic transformation, and for clearer
Table 1. Demographics and clinical profiles of study subjects.
All migraine
n¼ 92
CM
n¼ 28
EM
n¼ 64
HC
n¼ 32
Age, years 35.1 9.6 37.3 11.4 34.2 8.7 37.8 7.0
Gender, F/M 76/16 24/4 52/12 27/5
Headache frequency, days/month 12.3 8.8 24.3 4.1* 7.0 3.6* N/A
HADS_A† 7.1 3.9 9.3 3.7‡ 6.1 3.6‡ 3.0 2.2‡
HADS_D† 4.8 3.2 6.4 3.2‡ 4.0 2.9‡ 2.8 2.6
MIDAS 23.6 35.1 37.6 56.1* 17.4 17.5* N/A
*p< 0.001, CM vs. EM.
†one-way ANOVA, both p< 0.001.
‡post-hoc LSD, CM vs. EM, CM vs. HC, EM vs. HC, all p< 0.05.
Note: Data presented as mean SD, ‘all migraine’ stands for the pooled data of patients with both chronic and episodic migraine excluding those with
incomplete headache diary.
CM: chronic migraine; EM: episodic migraine; HC: healthy control; N/A: not applicable; HADS_A: anxiety section of Hospital Anxiety and Depression
Scale; HADS_D: depression section of Hospital Anxiety and Depression Scale; MIDAS: Migraine Disability Scale.
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comparisons we presented our results with raw values.
There were no significant differences between groups
regarding HPT or CPT.
Relationships between MPPTs and headache
frequency
The MPPTs decreased as headache frequency increased
and nadired (Figure 1). In the EM group, headache
frequency was negatively correlated with MPPTs in
both V1 and T1 dermatomes (r¼0.457, p< 0.001
and r¼0.518, p< 0.001). On the other hand, there
was no significant correlation between headache fre-
quency and MPPTs in the CM group.
Migraine phases and MPPTs
Among all 28 patients with CM, only one of them was
in the preictal phase and the rest were in the ictal phase.
Comparison between phases was not possible due to
the imbalance of distribution; therefore, comparisons
among migraine phases were only performed in EM
participants. Among patients with EM, 16 were in the
interictal phase, 20 in the preictal phase, 24 in the ictal
phase, and four in the postictal phase. MPPTs varied
by migraine phase in V1 (p< 0.001) and T1 (p< 0.001)
dermatomes. MPPTs in both dermatomes were higher
during the interictal phase compared with the preictal
(p¼ 0.021 and 0.003 for V1 and T1), ictal (p< 0.001
and <0.001 for V1 and T1), and postictal (p< 0.001
and <0.001 for V1 and T1) phases (Table 3). In both
V1 (p¼ 0.001) and T1 (p< 0.001) dermatomes, MPPTs
were significantly higher in EM patients during the
interictal phase compared with HCs. Pain thresholds
in the preictal, ictal, or postictal phases of EM patients
were similar compared to HCs.
Contributions of migraine phases and headache
frequency to MPPT
Predictors of MPPTs were determined by stepwise
linear analyses. Migraine phase was the strongest pre-
dictor of MPPTs in both V1 and T1 dermatomes
(b¼0.369, p¼ 0.003 and b¼0.416, p< 0.001), fol-
lowed by headache frequency (b¼0.298, p¼ 0.014
and b¼0.338, p¼ 0.004). The two-variable models
showed that migraine phase and headache frequency
independently explained 29.7% and 38.9% of the var-
iance in MPPTs in V1 and T1 dermatomes,
respectively.
Discussion
This study sought to investigate how headache frequen-
cy and migraine phase are related to HPT, CPT, and
MPPT in a heterogeneous population of migraine
patients. We found that a) QST results did not differ
between HCs and patients with CM; b) MPPTs
decreased with increasing headache frequency in
patients with EM; c) MPPT differed in different
migraine phases and decreased when approaching the
ictal phase in patients with EM. Migraine phases and
headache frequency together accounted for 30–40% of
total MPPT variance in EM patients. However, no sim-
ilar results were found for heat- or cold-induced pain
thresholds in our migraine patients.
Previous studies evaluating the relationship between
headache frequency and pain sensitivity are limited,
and studies that do assess these relationships are
often inconsistent. For example, HPT and headache
frequency appear to be unrelated in a study conducted
by Schwedt and colleagues (9); however, patients with
high headache frequency are more sensitive to heat
Table 2. Pain thresholds compared between groups.
All migraine
n¼ 92
CM
n¼ 28
EM
n¼ 64
HC
n¼ 32
V1
MPPT (g)* 109.3 40.2 94.5 34.5 115.8 41.0†‡ 96.0 43.9
HPT (C) 40.8 3.8 40.2 3.8 41.2 3.7 42.2 4.2
CPT (C) 21.4 7.6 22.8 7.3 20.4 7.8 22.5 14.6
T1
MPPT (g)* 114.4 65.9 85.5 33.8 127.0 72.5†‡ 103.7 54.9
HPT (C) 40.4 4.0 39.8 3.7 40.8 4.2 41.1 3.7
CPT (C) 20.0 8.4 21.3 8.3 19.0 8.6 19.2 10.2
Note: Data presented as mean SD, ‘all migraine’ stands for the pooled data of CM and EM.
*One-way ANOVA, p< 0.05.
†Post-hoc LSD, CM vs. EM, p< 0.05.
‡Post-hoc LSD, EM vs. HC, p< 0.05.
CM: chronic migraine; EM: episodic migraine; HC: healthy control; V1: first division of the 5th cranial nerve dermatome; T1: 1st
thoracic nerve dermatome; MPPT: mechanical punctate pain threshold; HPT: heat pain threshold; CPT: cold pain threshold.
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pain in Mathur and colleagues’ study (20). The current
study found that MPPT’s relationship with headache
frequency differed depended on headache frequency.
Specifically, as headache frequency increased, MPPT
declined gradually and reached nadir. More studies
with larger sample sizes are warranted to help us elu-
cidate the relationship between pain sensitivities and
headache frequency.
Migraine patients exhibited MPPTs during the inter-
ictal phase in both V1 and T1 dermatomes that were
significantly higher than any other phases. However,
the MPPTs declined at the preictal phase and remained
low during ictal and postictal phases. The MPPTs in
migraine patients were compatible with the mean
values of HCs during peri-ictal and ictal phases.
However, the number of patients in the ictal and
300(a)
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Figure 1. The relationship between headache frequency and the mechanical punctate pain thresholds (MPPTs) of (a) V1 and (b) T1
dermatomes. (a) and (b) show the pooled data of all migraine patients. The broken black lines represent the MPPTof healthy controls.
The black rectangular and the solid lines represent the mean and standard error of MPPTs within 1–3, 4–6, . . ., 22–24, and >24
monthly headache days.
EM: episodic migraine; CM: chronic migraine.
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postictal phases are relatively few. In contrast, to define
the phases of CM patients for the phase-wise analysis is
difficult, because many of them barely possessed an
interictal phase (Figure 2). Therefore, many patients
with CM are at a stage of never-ending migraine
attacks around peri-ictal phases; that is, from preictal
to postictal stages (26,27).
The current study has some methodological differ-
ences compared with previous MPPT studies. For
example, many previous studies use von Frey hairs
(17,23,28,29), very few used electronic von Frey devices
(24,30). The MPPT of our HCs (103.7 g) was compa-
rable with previous study (107.9 g) (30) using the same
rigid tip with similar electronic device tested on the
forearm. We did not compare the values from the
study of Reitz and colleagues (24) because their testing
area was the foot, which was not included in our study.
On the other hand, in the current study, HC HPTs
were similar to the previously reported values
(face: 42.2 4.2C vs. 41.5 4.1C; hand: 41.1
3.7C vs. 42.6 3.3C) (23).
HPT and CPT appeared to have no consistent rela-
tionship with clinical profiles among patients with
migraine in the current study, similar to previous stud-
ies (17–19). We do not know the exact mechanisms
accounting for the discrepancy of clinical correlations
for migraine patients in comparison with MPPT in our
study. Various receptors and fibers are responsible for
different types of pain (31): heat pain signals are largely
transferred along C fibers, whereas mechanical pain
and cold pain signals are mainly transferred along A
delta fibers. Even with the same transfer fibers, tran-
sient receptor potential cation channel subfamily M
(melastatin) member 8 serves as the transduction chan-
nel of cold-induced pain (32), whereas other receptors
such as potassium channel subfamily K member 4 (33),
transient receptor potential cation channel subfamily V
member 4 (34), and so on, are responsible for
Table 3. MPPT during different phases in patients with episodic migraine.
Interictal
n¼ 16
Preictal
n¼ 20
Ictal
n¼ 24
Postictal
n¼ 4
V1* 145.9 52.4† 117.0 23.9‡ 102.2 34.0 70.7 10.7
T1* 191.5 71.6† 127.3 63.7 94.7 53.9 61.5 22.3
Note: Data presented as mean SD.
*One-way ANOVA, both p< 0.001.
†Post-hoc LSD, interictal vs. preictal, ictal, and postictal, V1 p¼ 0.021, <0.001, <0.001 and T1 p¼ 0.003, <0.001, <0.001.
‡Post-hoc LSD, preictal vs. postictal, p¼ 0.023.
MPPT: mechanical punctate pain threshold; V1: first division of the 5th cranial nerve dermatome; T1: 1st thoracic nerve dermatome.
EM CM
M
P
P
T
HC
Day 14
Time
Day 28
Figure 2. A concept map illustrates the mechanical punctate pain thresholds (MPPT) change in migraine patients with different
headache frequencies.
EM: episodic migraine; CM: chronic migraine; HC: healthy control.
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mechanical punctate pain. These differences may lead
to the inconsistency of pain threshold changes in
patients with migraine. However, further studies are
needed to confirm these hypotheses.
We provide a concept figure of our study results
(Figure 2) in order to link with potential clinical prac-
tice. By conducting longitudinal MPPT assessments on
patients with EM, we may be able to predict a patient’s
next migraine attack. In addition, if a patient with EM
starts to show constant decreasing MPPT, he or she
may be in the early stages of chronification. With this
in mind, clinicians could use some of these data to ini-
tiate early detection and prevention of chronic
migraine. More importantly, our study demonstrated
that mechanical pain sensitivities differed with different
headache profiles, which likely explains, in part, why
previous studies do not show consistent results.
Our study does, however, have limitations. First,
our data were collected cross-sectionally, which may
result in less robust relationships between pain thresh-
olds and headache phases. A longitudinal study design
should be considered for future research. Second, the
number of patients in the postictal phase was small
compared with the other phases. This was inevitable
as our study was cross-sectional and pre-scheduled,
but can be averted with longitudinal study design.
Finally, because the current study was a single-center
hospital-based study, generalizing of our study results
should be cautious.
Conclusion
Collectively, our data suggest that MPPT is determined
by headache frequency and migraine phases, and
MPPTs decline when migraine patients approach ictal
stage or their headache become frequent. However,
future research, including a longitudinal study, is war-
ranted to confirm our study findings.
Clinical implications
• MPPT is determined by headache frequency and migraine phases.
• Our study demonstrated that mechanical pain sensitivities differed with different headache profiles, which
likely explains, in part, why previous studies do not show consistent results.
• We may be able to predict the next headache attack or chronification of migraine in patients by assessing
the MPPT. Future longitudinal studies are warranted to verify the predictability.
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